PAVmed Inc.
Net BuyingPAVM·US·🇺🇸 US
98%buys·2%sells
550 transactions$1.1MTotal buys·339 buys
$1.3MTotal sells·8 sells
2020 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 2, 26 | Baxter Timothy E | Grant | - | |
| Apr 2, 26 | Gordon Michael Adam | Grant | - | |
| Apr 2, 26 | Aklog Lishan | Grant | - | |
| Apr 2, 26 | Agrawal Sundeep | Grant | - | |
| Apr 2, 26 | Sparks Ronald M | Grant | - | |
| Apr 2, 26 | MCGRATH DENNIS M | Grant | - | |
| Apr 2, 26 | White Debra | Grant | - | |
| Apr 2, 26 | O'Neil Shaun | Grant | - | |
| Apr 2, 26 | Glennon Michael J | Grant | - | |
| Sep 30, 25 | O'Neil Shaun | Grant | - |
PAVmed Inc. (PAVM) has recorded 550 insider transactions from 20 insiders. Total insider buying volume stands at $1.1M, while total selling volume is $1.3M. Overall insider sentiment is bullish (98% purchases).
PAVmed Inc. (PAVM) has recorded 550 insider operations, including 339 open-market purchases ($1.1M), 8 sales ($1.3M) and 203 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (98% purchases).
Recent activity is concentrated over 2 months in the last year.
Among the most active insiders are Aklog Lishan (CEO), MCGRATH DENNIS M (CFO) & Fitzgerald Richard F (CFO), with respectively 151, 105, 15 transactions.
Across all 550 recorded transactions, the breakdown by type is: buys (339, 62%), grant (129, 23%), other (29, 5%), gift (15, 3%), exercise (14, 3%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
PAVmed Inc. has recorded 550 insider operations in total, including 339 open-market purchases ($1.1M), 8 sales ($1.3M) and 203 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at PAVmed Inc. are currently net buyers, with 98% purchases and 2% sales across all reported transactions. Total buy volume is $1.1M versus $1.3M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 20 insiders at PAVmed Inc. (PAVM). Aklog Lishan (CEO, 151 tx), MCGRATH DENNIS M (CFO, 105 tx), Fitzgerald Richard F (CFO, 15 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for PAVM is bullish, based on a 98% buy ratio across 347 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for PAVmed Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.